NCT00562380
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +57 more
- Locations
-
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,057 public trials
2,038 recruiting studies
Lymphoproliferative Disorders trial results
NCT00003554
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
Completed
Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib
NCT01060202
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
NCT00697671
- Conditions
- Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +28 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT01896752
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Department of Pediatrics, Rigshospitalet Copenhagen, Denmark
NCT00089154
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
- Locations
-
- Chronic Lymphocytic Leukemia Research Consortium (CRC) La Jolla, California, United States
- Ohio State University Medical Center Columbus, Ohio, United States
NCT01402687
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00006013
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- University of Chicago Cancer Research Center Chicago, Illinois, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT00062296
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Completed
Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
NCT00871702
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +19 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States